Jim Stephens serves as the President of Cardiac Rhythm Management & Neuromodulation at Integer Holdings Corporation, a leading medical device outsource manufacturer. With a robust background in the medical device industry, Stephens has been instrumental in driving innovation and growth within the company. Prior to joining Integer Holdings, he held various leadership positions at prominent medical technology firms, where he honed his expertise in strategic planning, product development, and operational excellence. In his current role at Integer Holdings, Stephens is responsible for overseeing the company's cardiac rhythm management and neuromodulation business units. His strategic vision has been pivotal in expanding the company's product portfolio and enhancing its market position. Under his leadership, Integer Holdings has successfully launched several cutting-edge medical devices that have improved patient outcomes and solidified the company's reputation as an industry leader. Stephens' commitment to fostering a culture of innovation and collaboration has been key to the sustained success of his division. Stephens holds a degree in Biomedical Engineering from a top-tier university, which has provided him with a solid foundation in the technical aspects of medical device development. Throughout his career, he has been recognized for his contributions to the field, receiving numerous awards and accolades. His ability to navigate complex regulatory environments and his dedication to advancing healthcare technology make him an invaluable asset to Integer Holdings Corporation.